FDA approves first drug to treat tardive dyskinesia - FDA Press Releases

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.

from Food and Drug Administration--Press Releases http://ift.tt/2owQ0C9
via IFTTT